Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.
The severity and longevity of inflammation is controlled by endogenous counter-regulatory signals. Among them are long-chain polyunsaturated fatty acid (PUFA)-derived lipid mediators, which promote the resolution of inflammation, an active process for returning to tissue homeostasis.To determine whe...
Main Authors: | Harald Prüss, Berit Rosche, Aaron B Sullivan, Benedikt Brommer, Oliver Wengert, Karsten Gronert, Jan M Schwab |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3568070?pdf=render |
Similar Items
-
The Effects of Proresolution of Ellagic Acid in an Experimental Model of Allergic Airway Inflammation
by: Claudiney de Freitas Alves, et al.
Published: (2013-01-01) -
In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis
by: Houda Abir Benabdoun, et al.
Published: (2019-03-01) -
Restoration of Proresolution Pathway with Exogenous Resolvin D1 Prevents Sevoflurane-Induced Cognitive Decline by Attenuating Neuroinflammation in the Hippocampus in Rats with Type 2 Diabetes Mellitus
by: Qingmei Sun, et al.
Published: (2021-07-01) -
GABAB receptor encephalitis in a patient diagnosed with amyotrophic lateral sclerosis
by: Heike Schumacher, et al.
Published: (2019-03-01) -
Measles IgG antibody index correlates with T2 lesion load on MRI in patients with early multiple sclerosis.
by: Berit Rosche, et al.
Published: (2012-01-01)